- Home
- LEGT vs STIM Comparison
LEGT vs STIM Comparison
Compare LEGT & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGT
- STIM
- Stock Information
- Founded
- LEGT 2023
- STIM 2003
- Country
- LEGT United States
- STIM United States
- Employees
- LEGT N/A
- STIM N/A
- Industry
- LEGT
- STIM Medical/Dental Instruments
- Sector
- LEGT
- STIM Health Care
- Exchange
- LEGT Nasdaq
- STIM Nasdaq
- Market Cap
- LEGT 274.3M
- STIM 232.3M
- IPO Year
- LEGT 2024
- STIM 2018
- Fundamental
- Price
- LEGT N/A
- STIM $3.40
- Analyst Decision
- LEGT
- STIM Buy
- Analyst Count
- LEGT 0
- STIM 4
- Target Price
- LEGT N/A
- STIM $6.00
- AVG Volume (30 Days)
- LEGT 16.6K
- STIM 884.9K
- Earning Date
- LEGT 01-01-0001
- STIM 08-11-2025
- Dividend Yield
- LEGT N/A
- STIM N/A
- EPS Growth
- LEGT N/A
- STIM N/A
- EPS
- LEGT 0.29
- STIM N/A
- Revenue
- LEGT N/A
- STIM $89,448,000.00
- Revenue This Year
- LEGT N/A
- STIM $104.65
- Revenue Next Year
- LEGT N/A
- STIM $10.69
- P/E Ratio
- LEGT $0.94
- STIM N/A
- Revenue Growth
- LEGT N/A
- STIM 22.16
- 52 Week Low
- LEGT $10.10
- STIM $0.52
- 52 Week High
- LEGT $10.86
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- LEGT N/A
- STIM 36.21
- Support Level
- LEGT N/A
- STIM $3.11
- Resistance Level
- LEGT N/A
- STIM $3.61
- Average True Range (ATR)
- LEGT 0.00
- STIM 0.20
- MACD
- LEGT 0.00
- STIM 0.01
- Stochastic Oscillator
- LEGT 0.00
- STIM 36.76
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.